Beyond just another Generative AI play

About Us

We take pride in assembling an extraordinary team of industry-leading experts to construct our groundbreaking AI protein design platform. Our handpicked talent pool boasts a rich history of publications and accolades, having received recognition and validation from esteemed leaders and organizations within the industry. For the past three years, our dedicated team has committed their efforts to perfecting our platform, drawing upon decades of combined experience in diverse fields such as protein design, computer science, AI, computational biology, chemistry, biology, and crystallography. Their collective wealth of knowledge is substantiated by a robust portfolio of over a dozen publications in revered peer-reviewed journals, complemented by their active participation in more than 20 conferences and seminars. At DiaGen, we are shaping the future of protein and peptide design with a team that epitomizes excellence and a commitment to innovation.

Our Team

Brian D. Keane

Brian D. Keane

CEO, Co-Founder, Executive Chairman

24+ years of capital markets experience,
$3 billion + investments transacted. Former advisor/banker at Rodman & Renshaw (now, HC Wainwright), Ladenburg Thalmann, NYSE:NDB (acquired by Deutsche Bank). Founder, director, advisor to dozens of Canadian private and public companies. Head of Capital Markets @ M37Capital.ai and Co Founder @ QualifiedCap.com.
Graduated University of Scranton;
JD, New York Law School

Paolo Lobo

Paolo Lobo

President

MSc Biochemistry: University of British Columbia (UBC). Paolo has over a decade of experience in the IVD & Biotech industry helping companies grow through strategic business development, regulatory hurdles, partnership and collaborations. His graduate work in crystallography led to several co-authored publications in high-impact journals such as Nature, Structure and the Biophysical Journal. Paolo’s structural biology insight from having solved several protein structures is a translatable skill needed in the computational biology problem of protein design.

Dr. Elliot Holtham

Dr. Elliot Holtham

COO, Artificial Intelligence Lead. Co-Founder

Entrepreneur and engineer specializing in AI.  Co-founded several technology start-ups and worked in diverse fields from quantum computing to genomics. Co-founder, CEO, COO of Xtract AI  acquired by Patriot One Technologies (TSX:PAT) now (Xtract One (TSX:XTRA). Co-founder of Railtown AI Technologies (CNSX: RAIL) and Co-Founder of M37Capital.ai

 

 

Dr. Eldad Haber

Dr. Eldad Haber

Chief Scientific Officer, Co-Founder

Professor of Computational Science and industrial research chair at the University of British Columbia. Recognized internationally as a world expert in the field of computational inverse problems. Fellow of the Society for Industrial and Applied Mathematics (SIAM). Writer of various software packages which been widely adopted by various industries. Award recipient of US Department of Energy Career. Co-founder of numerous successful technology startups focused on machine learning. Co-Founder of M37Capital.ai

Mohit Pandey

Mohit Pandey

AI Project Lead

Skilled in AI, ML,, NLP, and applied deep learning in life sciences with publications in multiple journals. He holds a M.S. in Computer Science from Rutgers University, B. Eng. in Electronics and Telecommunication from Shri G.S. and a Ph.D. in Bioinformatics (ML) from UBC, expected Winter 24’ Formerly at Recursion (Nasdaq:RXRX), his add’l experience includes, Vancouver Prostate Centre, Ipsos Public Affairs, Signzy Technologies, Weill Cornell Medicine.
Awards: CIHR Doctoral award, UBC 4 Yr Fellowship, UBC President’s Academic Excellence Initiative Ph.D. Award. Key projects involve binding affinity prediction using protein structural graphs and graph neural networks.

Eric Baum

Eric Baum

Director

Founding Director with 20+ years experience advising Executive leadership teams for Fortune 50 companies Co-Founder / Managing Director of Solidea Capital. Solidea (“Solid Idea”) Managing Director / Executive Board Member of Acquis Consulting Group. Founding Partner of Summit Holdings. Member of several angel investment groups, such as the Charlotte Angel Fund. Director of multiple Private and Public Companies specializing in Corporate Governance. Graduated Emory University Valedictorian

Andrew Chan

Andrew Chan

CFO

Experienced in the financial workings of early startups including raising funds, accounting, corporate transactions and capital markets. Former finance Manager at Electronic Arts. Former Head of Finance and Admin @ Xtract AI, a Machine Learning company acquired by Patriot One Technologies (TSX:PAT) which was recently rebranded as Xtract One (TSX:XTRA). Graduate UBC in Accounting

Advisors

Cory Brandolini

Cory Brandolini

CEO – Railtown.ai

30+ years as founder, advisor, investor, financier to disruptive, high-growth Ai and tech companies.

Neil Crabb

Neil Crabb

CEO – Frontier IP

Commercializing tech intellectual property, and corporate strategy

Bas Peters

Bas Peters

PhD

Specializing in constrained optimization and machine learning applications of protein design

Ashley George

Ashley George

PhD

17 years at GSK, 8 years as the Global Head of Innovation and Consumerization Centre of Excellence

Lior Horesh

Lior Horesh

PhD

Associate Professor at Columbia ‎University.
Senior Manager, Mathematics of AI – IBM

Alison Axtman

Alison Axtman

PhD

Principal Investigator at the Structural Genomics Consortium, University of North Carolina.